IFEX
IFEX
Approved
DIN Number
02241357
Drug Class
Human
Market Date
Mar 20, 2001
Company
HC
baxter corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02241357
AIG Number0120706002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01AA06 IFOSFAMIDE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
IFOSFAMIDEActive
Strength: 1 G / VIAL
Monograph: IFOSFAMIDE